$-0.01 EPS Expected for Bovie Medical Corporation (BVX)

March 11, 2018 - By Henry Gaston

 $ 0.01 EPS Expected for Bovie Medical Corporation (BVX)
Investors sentiment increased to 1.21 in Q3 2017. Its up 0.14, from 1.07 in 2017Q2. It increased, as 6 investors sold Bovie Medical Corporation shares while 8 reduced holdings. 11 funds opened positions while 6 raised stakes. 8.25 million shares or 5.67% more from 7.81 million shares in 2017Q2 were reported.
National Bank & Trust Of America De has 0% invested in Bovie Medical Corporation (NYSEAMERICAN:BVX) for 1,571 shares. Renaissance Technologies Ltd Liability Company has invested 0% of its portfolio in Bovie Medical Corporation (NYSEAMERICAN:BVX). Atria Ltd Llc reported 10,000 shares stake. Bridgeway Capital Management has 0.01% invested in Bovie Medical Corporation (NYSEAMERICAN:BVX) for 156,470 shares. Barclays Public Ltd Com reported 0% of its portfolio in Bovie Medical Corporation (NYSEAMERICAN:BVX). Sei invested 0% of its portfolio in Bovie Medical Corporation (NYSEAMERICAN:BVX). The New York-based Morgan Stanley has invested 0% in Bovie Medical Corporation (NYSEAMERICAN:BVX). Manufacturers Life Insur The accumulated 2,983 shares or 0% of the stock. Great Point Prtnrs Lc holds 1.2% of its portfolio in Bovie Medical Corporation (NYSEAMERICAN:BVX) for 1.83M shares. Vanguard Group owns 864,386 shares for 0% of their portfolio. Perkins Mgmt has invested 2.21% of its portfolio in Bovie Medical Corporation (NYSEAMERICAN:BVX). Royal Savings Bank Of Canada, a Ontario – Canada-based fund reported 4 shares. Raymond James Fincl Services Advisors owns 109,950 shares or 0% of their US portfolio. Horizon Kinetics Limited Liability Corporation owns 615,000 shares. California Employees Retirement Sys accumulated 28,177 shares.

Analysts expect Bovie Medical Corporation (NYSEAMERICAN:BVX) to report $-0.01 EPS on March, 12 after the close.They anticipate $0.03 EPS change or 75.00 % from last quarter’s $-0.04 EPS. After having $-0.04 EPS previously, Bovie Medical Corporation’s analysts see -75.00 % EPS growth. The stock decreased 1.25% or $0.03 during the last trading session, reaching $2.37. About 23,847 shares traded. Bovie Medical Corporation (NYSEAMERICAN:BVX) has risen 28.74% since March 11, 2017 and is uptrending. It has outperformed by 12.04% the S&P500.

Bovie Medical Corporation, a medical device company, develops, makes, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company has market cap of $77.88 million. The firm provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It currently has negative earnings. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians in the areas of gynecology, general surgery, and urology.

More notable recent Bovie Medical Corporation (NYSEAMERICAN:BVX) news were published by: Reuters.com which released: “BRIEF-Bovie Medical Corp Appoints Topaz Kirlew As Director Of Regulatory Affairs” on March 06, 2018, also Businesswire.com with their article: “Bovie Medical Corporation to Release Fourth Quarter and Fiscal Year 2017 …” published on February 12, 2018, Businesswire.com published: “Bovie Medical Corporation Announces Enrollment of First Patient in J-Plasma” on January 23, 2018. More interesting news about Bovie Medical Corporation (NYSEAMERICAN:BVX) were released by: Businesswire.com and their article: “Bovie Medical Corporation to Release Third Quarter 2017 Financial Results on …” published on October 17, 2017 as well as Businesswire.com‘s news article titled: “Bovie Medical Corporation Reports Third Quarter 2017 Financial Results and …” with publication date: November 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: